CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Planned sale Director sold 18,373.33 shares at an average $79.19 ($1,454,989)
- 4 Planned sale Director sold 2,500 shares at $78.50 ($196,250)
- 4 Gift Director gave 2,012 shares (gift)
- 4 Shares withheld for taxes See Remarks gave up 1,466 shares (to pay taxes)
- 4 Planned sale Chief Accounting Officer sold 341 shares at $76.89 ($26,219)
- 4 Shares withheld for taxes Director gave up 629 shares (to pay taxes)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Grant or award Director acquired 2,635 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 177 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 455 shares (to pay taxes)
- 4 Planned sale Chief Accounting Officer sold 341 shares at $61.24 ($20,883)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CFO and Treasurer sold 20,000 shares at $60.00 ($1,200,000)
- 4 Planned sale Chief Accounting Officer sold 341 shares at $60.48 ($20,624)
Page 6 of 30 · 598 filings